Discover 60 paid clinical trials in Bangor, Maine. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 60
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Location: Brewer ME, Augusta ME, Londonderry NH, Methuen MA,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 60+
Code: NCT06377852
Phase3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Improving Health Outcomes Through Investigations of Wabanaki Food Systems in Maine
for
Food Insecurity
Location: Bangor ME
Sponsor: Wabanaki Public Health and Wellness
Sex: All
Age: 18+
Code: NCT07561593
Recruiting
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
for
Pulmonary Disease, Chronic Obstructive
Location: Bangor ME, Kingston, West Chester PA, DuBois PA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT07177339
Phase3, Recruiting
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
for
Pulmonary Disease, Chronic Obstructive
Location: Bangor ME, New Windsor NY, Mount Kisco NY,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT06961214
Phase3, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Bangor ME, Sherbrooke, Quebec, Boston MA,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase3, Recruiting
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
for
Heart Failure, Heart Failure With Reduced Ejection Fraction
Location: Bangor ME, Boston MA, Terrebonne, Montreal, Hartford CT,
Sponsor: Cytokinetics
Sex: All
Age: 18 - 70+
Code: NCT06736574
Phase3, Recruiting
Micronutrients as Adjunctive Treatment for Bipolar Disorder
for
Bipolar Disorder
Location: Bangor ME
Sponsor: Eastern Maine Medical Center
Sex: All
Age: 18+
Code: NCT03541031
Recruiting
I-DECIDE After Bronchiolitis Hospitalization
for
Bronchiolitis Acute
Location: Bangor ME, Manchester NH, Boston MA, Providence RI,
Sponsor: Seattle Children's Hospital
Sex: All
Age: 0 - 2
Code: NCT07243652
Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)